Skip to main content
Egyptian Liver Journal

Table 1 Demographic data and parameters of the studied groups

From: Thrombophilia in hepatocellular carcinoma

Variables   Control group Cirrhotic patients HCC patients P value Post hoc analysis
Number   45 70 70   
Age   54.8 ± 7.19 55 ± 6.43 56.87 ± 6.26 0.148*  
Sex (male/female)   23/22 40/30 42/28 χ2 0.6413  
Etiology       
 Chronic hepatitis C   – 45 48 χ2 0.8369  
 Chronic hepatitis B   – 9 10  
 Non-alcoholic steatohepatitis   – 8 5  
 Autoimmune hepatitis   – 6 4  
 Cryptogenic   – 2 3  
Child-Pugh’s score       
 Child A   – 3 4 χ2 0.224  
 Child B   – 20 29  
 Child C   – 47 37  
MELD score   – 15 (4–25) 19 (10–40) < 0.001**  
AFP (ng/ml)   6 (2–15) 8 (2–20) 1700 (500–3500) 0.000*** P1 = 0.97
P2 < 0.001
P3 < 0.001
  1. Values are expressed as the mean ± standard deviation (SD) while values of MELD score and AFP are given as the median and interquartile range (IQR)
  2. Significant difference (P value < 0.05)
  3. χ2 chi-square test, P1 control group vs cirrhotic patients, P2 control group vs HCC patients, P3 cirrhotic patients vs HCC patients, MELD model for end-stage liver disease, AFP α-fetoprotein
  4. *ANOVA test
  5. **Mann-Whitney U test
  6. ***Kruskal-Wallis test
Back to article page